Clinical Trial Update: Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia

View source ↗

Summary

This entry notes an ongoing clinical trial from the National Institute on Aging evaluating glucose metabolism, amyloid, and tau brain imaging in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Down Syndrome, Alzheimer's Disease | Status: UNKNOWN